203
Views
14
CrossRef citations to date
0
Altmetric
Original Research

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study

, , , &
Pages 1977-1984 | Published online: 21 Nov 2017

References

  • KantorEDRehmCDHaasJSChanATGiovannucciELTrends in prescription drug use among adults in the United States from 1999–2012JAMA2015314171818183126529160
  • PrattLABrodyDJGuQAntidepressant use in persons aged 12 and over: United States, 2005–2008NCHS Data Brief20117618
  • CouplandCDhimanPMorrissRArthurABartonGHippisley-CoxJAntidepressant use and risk of adverse outcomes in older people: population based cohort studyBMJ2011343d455121810886
  • KarkareSUBhattacharjeeSKamblePAparasuRPrevalence and predictors of antidepressant prescribing in nursing home residents in the United StatesAm J Geriatr Pharmacother20119210911921565710
  • CarsonHJZweigartMLueckNEDeath from asthma associated with sertraline overdoseAm J Forensic Med Pathol200021327327510990292
  • TurnerRCNelsonJERobertsBTGillamDMVenlafaxine-associated interstitial pneumonitisPharmacotherapy200525462662915977923
  • BarnésMTBascuñanaJGarcíaBAlvarez-SalaJLAcute eosinophilic pneumonia associated with antidepressant agentsPharm World Sci199921524124210550851
  • EspeletaVJMooreWHKanePBBaramDEosinophilic pneumonia due to duloxetineChest2007131390190317356112
  • FleischMCBlauerFGublerJGKuhnMSchererTAEosinophilic pneumonia and respiratory failure associated with venlafaxine treatmentEur Respir J200015120520810678647
  • ThorntonCMaherTMHansellDNicholsonAGWellsAUPulmonary fibrosis associated with psychotropic drug therapy: a case reportJ Med Case Rep2009312620062766
  • TsigkaropoulouEHatziliaDRizosEVenlafaxine-induced acute eosinophilic pneumoniaGen Hosp Psychiatry2011334411.e7e9
  • VázquezMJCarretero QuevedoBPneumonitis related to venlafaxinePsychosomatics2008491848518212183
  • DrentMSinghSGorgelsAPDrug-induced pneumonitis and heart failure simultaneously associated with venlafaxineAm J Respir Crit Care Med2003167795896112663337
  • de KervilerETrédanielJRevlonGFluoxetine-induced pulmonary granulomatosisEur Respir J1996936156178730028
  • TorokNIDonaldsonBLTajiJAbugiazyaAAssalyRDiffuse alveolar damage and recurrent respiratory failure secondary to sertralineAm J Ther2012194e132e13520838205
  • OhSChaSIKimHA case of venlafaxine-induced interstitial lung diseaseTuberc Respir Dis (Seoul)2014772818425237379
  • FerreiraPGCostaSDiasNFerreiraAJFrancoFSimultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxineJ Bras Pneumol201440331331825029655
  • CoultasDBZumwaltREBlackWCSobonyaREThe epidemiology of interstitial lung diseasesAm J Respir Crit Care Med199415049679727921471
  • RaghuGWeyckerDEdelsbergJBradfordWZOsterGIncidence and prevalence of idiopathic pulmonary fibrosisAm J Respir Crit Care Med2006174781081616809633
  • OlsonALSwigrisJJLezotteDCNorrisJMWilsonCGBrownKKMortality from pulmonary fibrosis increased in the United States from 1992 to 2003Am J Respir Crit Care Med2007176327728417478620
  • GribbinJHubbardRBLe JeuneISmithCJWestJTataLJIncidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKThorax2006611198098516844727
  • KornumJBChristensenSGrijotaMThe incidence of interstitial lung disease 1995–2005: a Danish nationwide population-based studyBMC Pulm Med200882418983653
  • ArakiTPutmanRKHatabuHDevelopment and progression of interstitial lung abnormalities in the Framingham Heart StudyAm J Respir Crit Care Med2016194121514152227314401
  • RosenbergTAcute hospital use, nursing home placement, and mortality in a frail community-dwelling cohort managed with Primary Integrated Interdisciplinary Elder Care at HomeJ Am Geriatr Soc20126071340134622694020
  • RockwoodKSongXMacKnightCA global clinical measure of fitness and frailty in elderly peopleCMAJ2005173548949516129869
  • AllenJNDrug-induced eosinophilic lung diseaseClin Chest Med2004251778815062599
  • MatsunoODrug-induced interstitial lung disease: mechanisms and best diagnostic approachesRespir Res2012133922651223
  • CapelozziMALeick-MaldonadoEAParraERMartinsMATibérioIFCapelozziVLMorphological and functional determinants of fluoxetine (Prozac)-induced pulmonary disease in an experimental modelRespir Physiol Neurobiol2007156217117817056303
  • ChangMTybringGDahlMLLindhJDImpact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysisClin Pharmacokinet201453980181125154506
  • NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508